While the United States on Wednesday secured a deal with Pfizer Inc. for an additional 100 million doses of its Covid-19 vaccine, the cases of allergic reactions have sparked discussions between vaccine manufacturers and the National Institutes of Health (NIH) to conduct clinical analysis. trials in highly allergic populations. According …
Read More »